Medical Affairs Is Moving Into the Moment
What’s changing across data, engagement, and the pace of execution At the 2026 MAPS Annual Meeting, Medical Affairs teams described how their approach is changing....
Featured News
Scientific Exchange in a Social World
What Med Comms teams need to know about modern platforms Medical Communications has always been about getting the science right. That part hasn’t changed. What’s...
Real Chemistry Strengthens Global Presence with New International Leadership Appointments and Expanded Regional Hubs
Latest investment marks key milestone in the company’s global growth strategy, supporting clients across an increasingly complex healthcare landscape LONDON, Feb. 5, 2026 – Real...
Creativity in Medical Communications Thrives When We Stop Predicting the No
Anyone who works in pharma knows how quickly creative ambition shrinks under the weight of review. What’s less obvious is that most ideas aren’t rejected...
[Report] Beyond the Breakthrough: Turning Oncology Guidelines into Clinical Reality
Survey insights from 150 oncologists in the UK, France, and Germany on the barriers and opportunities in guideline adoption. A medical breakthrough truly becomes impactful...
Launch Like You Mean It: Turning Medical + Commercial Alignment Into Results
One-third of all new launches in the US fail to meet expectations.1 Not because the science isn’t strong, but because medical affairs and commercial teams...
[Report] Innovate to Educate: Applying Adult Learning Principles to Medical Education
Is Your Peer-to-Peer Deck Indicated as a Sleep Aid? At Real Chemistry Medical Communications, we believe in breaking the mold to create peer-to-peer educational experiences...
#MedComms Day: When Science Gets Personal
This #MedComms Day, we’re making science personal. This isn’t just a theme—it’s our mantra. We’re transforming the landscape of medical communications by making science resonate...
[Report] Cracking the Code of Oncology Commercialization
Where Science Meets the Soul of Storytelling The pace of oncology innovation is staggering. Are your strategies keeping up? More than 50 new cancer medicines...
